Video: New Topical Drug Delivery System, NeuroDirect™

Must Watch Video. Topical Application to Improve Delivery of FDA-Approved Drugs. https://youtu.be/2CGT7P9QEvo Can...
Psychedelic Stock Review

Cybin (CYBN) Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using...

October 26, 2021 07:30 AM Eastern Daylight Time TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biotechnology...

Huge News at Ehave Inc.(EHVVF), our Favorite Psychedelic.

We just finished compiling the 2021 Psychedelic Investor Guide and reviewed 44 companies - in all shapes and sizes. Excluding Johnson &...
Revive Therapeutics

Revive Therapeutics (RVVTF) Moves a Step Closer to FDA Verdict for Its Novel Covid...

Two Binary Events Directly Ahead. As in Months Away, not Years. Share Price up 76% During April.
Greenbrook Health

Greenbrook Health Centers (GBNH) Changing the Way Depression is Treated.

Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence https://youtu.be/yrr-wlFftT0
Psychedelic Stock Review

Psychedelic Investor Conferences.

Not Quite as Popular as the Bitcoin 2021 Conference Attended by 12,000 - But Worth Considering!
SILO Pharmaceutical, Psychedelic Stock Review

Silo Pharma (SILO) Announces Positive Study Results of SPU- 21 for Arthritis

SPU-21 effective in controlling arthritis progression. SPU-21 Demonstrates Positive Data in Arthritis Suppression using Silo’s Novel Joint Homing Peptide

Revive Therapeutics (RVVTF) Enters the Danger Zone.

What Danger You Ask? Danger #1, the FDA doesn't like the data, and you own the stock.

Cybin (CYBN) Announces Unprecedented Positive Phase 2 Data After Single Dose.

Conference call to discuss CYB003 interim results today, November 1, 2023 at 11:00 a.m. ET

Psychedelics CURED My Alcoholism

RELATED: Matthew Perry Reveals he Spent About $9M Trying to get Sober. Psychedelics CURED...

Latest article

Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...

Major Mpox Outbreak in the Democratic Republic of Congo.

As Reported in NPR's Gates and Soda Major Mpox Outbreak in the Democratic Republic of Congo is a...

Mpox Infections Rise to Almost Double Last Year’s Numbers.

The number of mpox cases in 2024 is already nearly double the number of cases that were detected in all of...